Orchestra Biomed Holdings (OBIO): Director had shares withheld for tax 4,238 shares
Chris Cleary, Director at Orchestra Biomed Holdings, reported a tax withholding of 4,238 shares.
- 4,238
- Shares · @ $4.42
- Traded
- Aug 12, 2026
- Filed
- Aug 14, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 1, 2026InsiderDirector sold ~$64K of OBIO shares in the open market
- Aug 3, 2026InsiderDirector sold ~$61K of OBIO shares in the open market
What came next
- Aug 26, 2026InsiderDirector purchased ~$11K of OBIO shares in the open market
- Sep 1, 2026InsiderDirector sold ~$74K of OBIO shares in the open market
- Sep 3, 2026InsiderDirector purchased ~$48K of OBIO shares in the open market
- Oct 1, 2026InsiderDirector sold ~$95K of OBIO shares in the open market
- Nov 2, 2026InsiderDirector sold ~$86K of OBIO shares in the open market
- Nov 9, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Nov 9, 2026Insider · 5 peopleInsiders: 5 purchases (~$6.2M)
- Nov 12, 20265% stakeRTW Investments, LP filed an activist stake (13D) of 16.2%
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Orchestra Biomed Holdings
For Orchestra Biomed Holdings, OQRO holds 11 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OBIO page.
How this filing works
Explore the data
Other disclosures at Orchestra Biomed Holdings
- SEC Schedule 13DNov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its OBIO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data